1. Market Research
  2. > DiaMedica Inc. - Product Pipeline Review - 2013

DiaMedica Inc. - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 36 pages

DiaMedica Inc. - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “DiaMedica Inc. - Product Pipeline Review - 2013” provides data on the DiaMedica Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, DiaMedica Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from DiaMedica Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- DiaMedica Inc. - Brief DiaMedica Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of DiaMedica Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of DiaMedica Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the DiaMedica Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate DiaMedica Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of DiaMedica Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the DiaMedica Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with DiaMedica Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of DiaMedica Inc. and identify potential opportunities in those areas.

Table Of Contents

DiaMedica Inc. - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
DiaMedica Inc. Snapshot 5
DiaMedica Inc. Overview 5
Key Information 5
Key Facts 5
DiaMedica Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
DiaMedica Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
DiaMedica Inc. - Pipeline Products Glance 11
DiaMedica Inc. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
DiaMedica Inc. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
DiaMedica Inc. - Drug Profiles 15
deferoxamine 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
DM-199 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
DM-204 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
DM-365 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
DM-433 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
DM-711 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
DM-99 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
SAN-18 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
DiaMedica Inc. - Pipeline Analysis 23
DiaMedica Inc. - Pipeline Products by Therapeutic Class 23
DiaMedica Inc. - Pipeline Products By Target 25
DiaMedica Inc. - Pipeline Products by Route of Administration 26
DiaMedica Inc. - Pipeline Products By Mechanism of Action 27
DiaMedica Inc. - Recent Pipeline Updates 29
DiaMedica Inc. - Dormant Projects 33
DiaMedica Inc. - Locations And Subsidiaries 34
Head Office 34
Other Locations and Subsidiaries 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 36
Disclaimer 36

List of Tables

DiaMedica Inc., Key Information 5
DiaMedica Inc., Key Facts 5
DiaMedica Inc. - Pipeline by Indication, 2013 8
DiaMedica Inc. - Pipeline by Stage of Development, 2013 9
DiaMedica Inc. - Monotherapy Products in Pipeline, 2013 10
DiaMedica Inc. - Phase II, 2013 11
DiaMedica Inc. - Phase I, 2013 12
DiaMedica Inc. - Preclinical, 2013 13
DiaMedica Inc. - Discovery, 2013 14
DiaMedica Inc. - Pipeline By Therapeutic Class, 2013 24
DiaMedica Inc. - Pipeline By Target, 2013 25
DiaMedica Inc. - Pipeline By Route of Administration, 2013 26
DiaMedica Inc. - Pipeline Products By Mechanism of Action, 2013 28
DiaMedica Inc. - Recent Pipeline Updates, 2013 29
DiaMedica Inc. - Dormant Developmental Projects,2013 33
DiaMedica Inc., Other Locations 34

List of Figures

DiaMedica Inc. - Pipeline by Indication, 2013 7
DiaMedica Inc. - Pipeline by Stage of Development, 2013 9
DiaMedica Inc. - Monotherapy Products in Pipeline, 2013 10
DiaMedica Inc. - Pipeline By Therapeutic Class, 2013 23
DiaMedica Inc. - Pipeline By Route of Administration, 2013 26
DiaMedica Inc. - Pipeline Products By Mechanism of Action, 2013 27

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.